- Home
- BSAC vs BMRN Comparison
BSAC vs BMRN Comparison
Compare BSAC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSAC
- BMRN
- Stock Information
- Founded
- BSAC 1977
- BMRN 1996
- Country
- BSAC Chile
- BMRN United States
- Employees
- BSAC N/A
- BMRN N/A
- Industry
- BSAC Commercial Banks
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- BSAC Finance
- BMRN Health Care
- Exchange
- BSAC Nasdaq
- BMRN Nasdaq
- Market Cap
- BSAC 11.5B
- BMRN 12.1B
- IPO Year
- BSAC 1994
- BMRN 1999
- Fundamental
- Price
- BSAC $24.64
- BMRN $58.86
- Analyst Decision
- BSAC Hold
- BMRN Buy
- Analyst Count
- BSAC 3
- BMRN 22
- Target Price
- BSAC $21.33
- BMRN $93.43
- AVG Volume (30 Days)
- BSAC 510.9K
- BMRN 1.6M
- Earning Date
- BSAC 04-30-2025
- BMRN 05-01-2025
- Dividend Yield
- BSAC 4.03%
- BMRN N/A
- EPS Growth
- BSAC 111.01
- BMRN 152.82
- EPS
- BSAC 0.01
- BMRN 2.71
- Revenue
- BSAC $2,379,764,303.00
- BMRN $2,950,227,000.00
- Revenue This Year
- BSAC $39.14
- BMRN $12.27
- Revenue Next Year
- BSAC $5.12
- BMRN $9.86
- P/E Ratio
- BSAC $10.85
- BMRN $21.79
- Revenue Growth
- BSAC 49.00
- BMRN 19.36
- 52 Week Low
- BSAC $18.14
- BMRN $52.93
- 52 Week High
- BSAC $24.90
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- BSAC 60.41
- BMRN 37.63
- Support Level
- BSAC $23.12
- BMRN $58.74
- Resistance Level
- BSAC $24.77
- BMRN $61.26
- Average True Range (ATR)
- BSAC 0.54
- BMRN 1.98
- MACD
- BSAC 0.02
- BMRN -0.03
- Stochastic Oscillator
- BSAC 83.70
- BMRN 1.80
About BSAC Banco Santander - Chile ADS
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.